The Food and Drug Administration (FDA) announced the publication of a Request for Applications for a grant program to support the development of new animal drugs intended for minor species or minor uses in major species (major species are horses, dogs, cats, cattle, pigs, turkeys and chickens).
The grant program was established by the Minor Use and Minor Species (MUMS) Animal Health Act of 2004 and FDA has $750,000 to offer in MUMS grants for the fiscal year ending Sept. 30, 2010.
In accordance with the statute, a MUMS grant must be for the purpose of "defraying the costs of qualified safety and effectiveness testing expenses incurred in connection with the development of designated new animal drugs." Qualified testing occurs after the date a drug is designated under Section 573 of the act and before the date on which a new animal drug application for the drug is submitted under Section 512 of the act. In addition, a study for which a grant is sought must be subject to a protocol accepted by the Center for Veterinary Medicine prior to the submission of a grant application.
Grants for total costs will be available for up to $50,000 per year for up to two years for routine studies; and up to $100,000 per year for up to two years for studies of unusual complexity, duration or size. A third year of funding may be available for long-term toxicology studies. Therefore, grants could range from under $50,000 for a routine study that could be completed in less than a year to $200,000 for a complex study requiring two years for completion to $300,000 for a long-term toxicology study.
The complete Request for Applications announcement is available at http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-10-001.html, and applications for fiscal year 2010 funding must be submitted electronically through www.grants.gov/ by May 14.